PET

Short-wave infrared Cerenkov imaging to better visualize targeted radiotherapy and diagnostic radiotracers

SUMMARY. The problem: Cerenkov luminescence (CL) imaging (CLI) is a new imaging method that utilizes light emitted during decay of radiotracers. CLI merges optical and nuclear imaging by utilizing affordable yet highly sensitive optical cameras with clinical radiotracers. It provides fast and cheap clinical optical imaging to explore radiotracer distribution in patients. While not tomographic, CLI systems have a lower price, smaller footprint and higher resolution than nuclear imaging scanners. Yet, due to the very low signal intensity of CL its versatility remains limited since CLI requires strict exclusion of ambient light with an enclosure. Therefore, CLI requires novel approaches to make clinical imaging more feasible. We hypothesized that we could explore the short-wave infrared (SWIR) part of CL to enable CLI under ambient light without enclosure, providing improved and facile CLI, particularly of isotopes used for therapy that cannot be imaged otherwise. SWIR imaging (900- 1300 nm) has almost no autofluorescence, absorption or scatter but provides significantly higher depth penetration, yielding images with higher contrast and resolution compared to the visible range. Since typical LEDs do not emit light beyond 850 nm, they do not interfere with the SWIR camera. We can therefore perform CLI in the SWIR range (SWIR-CLI) without the limiting light-tight box and under ambient LED light and also achieve better signal penetration and accuracy. We will investigate if SWIR-CLI can be used to monitor distribution of therapeutic isotopes for targeted radiotherapy (TRT), a fast-expanding field as highlighted by Novartis’ acquisition of Lutathera and Pluvicto for the price of $6 bn. These agents are targeting 177Lu as therapy to neuroendocrine and prostate cancers. For TRT α-emitting isotopes are particularly attractive due to the α- particle’s short path length with high linear energy transfer. However, α-emitters are very difficult to image with conventional equipment. The α-emitter could be swapped with an imaging isotope, but this can alter the agent’s biodistribution. The α-particle itself does not have sufficient energy to produce CL but several daughters in the decay chains of most α-emitters produce electrons with sufficient energy to create CL. We have already imaged the α-emitter 223Ra in patients and have recently shown that CLI of α-emitters in the SWIR is possible. SWIR- CLI could therefore provide a facile imaging approach for α-emitters. We will answer with our three independent Aims the following questions: (1) Can we image diagnostic isotopes with SWIR-CLI? (2) Can we image therapeutic emitters with SWIR-CLI? (3) Can we use SWIR-CLI to image patients undergoing PET and/or TRT? Animal studies will employ established mouse cancer models to optimize imaging parameters and validate findings, directly informing the co-clinical Aim 3 trial. By eliminating the requirement for a light-tight enclosure and enabling CLI under ambient light, SWIR-CLI represents a significant shift in the practical deployment of CLI rather than an incremental improvement. Our study will broaden the reach of CLI by enabling imaging under ambient lighting, unlocking innovative new opportunities for CLI (monitoring TRT) in research & clinical settings.

Targeting the Molecular Crosstalk Between EZHIP and PRC2 in PFA Ependymoma

Project Summary: PFA ependymoma is a rare and aggressive pediatric brain tumor with a poorly understood molecular mechanism. Unlike many cancers, PFA ependymoma exhibits very few genetic alterations. Instead, it is thought to be driven primarily by epigenetic dysregulation. A key player in this disease is the EZH1/2 inhibitory protein EZHIP, which is normally expressed only in germ cells. EZHIP is aberrantly expressed in PFA ependymoma, where it disrupts the function of Polycomb Repressive Complex 2 (PRC2), a master epigenetic regulator of developmental gene repression through deposition of the trimethylated histone H3 lysine 27 (H3K27me3) repressive histone mark. EZHIP-mediated dysregulation of PRC2 involves both enzymatic inhibition and physical stalling of PRC2 on CpG island (CGI) chromatin, leading to a global loss of H3K27me3 levels, an epigenetic hallmark of PFA ependymoma. PRC2 itself is a highly dynamic and intricate complex that assembles into two functional variants, PRC2.1 and PRC2.2. These two variants share a core composed of the catalytic subunits EZH1/2, along with EED, SUZ12, and RBBP4/7, and differ by incorporating distinct accessory subunits. PRC2.1 includes PHF1/MTF2/PHF19, EPOP, and PALI1/2, while PRC2.2 features AEBP2 and JARID2. Our preliminary data reveal intriguing molecular crosstalk between EZHIP and multiple PRC2 components, suggesting potential competitive or cooperative interplay. The ability of EZHIP to inhibit PRC2 partly stems from its mimicry of the oncohistone H3K27M, which harbors a lysine-to-methionine mutation that causes diffuse midline glioma, another devastating brain tumor in children, where PRC2 activity is also globally suppressed. However, the precise, EZHIP-specific mechanisms behind PRC2 dysregulation in PFA ependymoma remain largely unexplored. Our work aims to uncover these elusive mechanisms using a powerful combination of structural biology, biochemistry, and genomics approaches. Ultimately, we aim to identify therapeutic strategies that disrupt the pathogenic EZHIP–PRC2 crosstalk and restore the normal H3K27me3 epigenetic landscape. Specifically, in Aim 1, we will determine the structural and biochemical mechanisms underlying the enzymatic inhibition of the PRC2 core complex by EZHIP. In Aim 2, we will elucidate the molecular basis of EZHIP-mediated stalling of PRC2 on CGI chromatin, involving PRC2 functional variants. In Aim 3, we will explore an exciting mechanism-based therapeutic strategy to overcome PRC2 enzymatic inhibition and chromatin stalling induced by EZHIP.

Research on End-user Acceptability.and Long-term Impacts of HIV Cure Strategies (REALISE)

ABSTRACT Despite remarkable advances in HIV cure science, emerging cure candidates will likely involve trade-offs (e.g., incomplete eradication, monitoring burdens) and must compete with increasingly convenient long-acting ART; without early implementation guidance, even efficacious products may see limited uptake, particularly among the ~30–40% of people with HIV (PWH) in the U.S. who are not durably suppressed. We propose REALISE, a multidisciplinary program to define plausible cure profiles, quantify end-user preferences, and project population-level impact to inform product design and policy before market entry. Aim 1 conducts qualitative interviews with ~30 researchers and developers to delineate credible 10–20-year cure and long-acting treatment scenarios (eradication vs functional control, safety, monitoring, durability), yielding bounded “target product profiles.” Aim 2 elicits patient-centered preferences through a two-stage study: formative interviews (n=60; ≥50% not virally suppressed) to identify salient attributes; best-worst scaling (n=360 across Missouri, Georgia, and San Francisco) to prioritize attributes; and a discrete choice experiment (n=360) to quantify trade-offs versus alternative therapies, with latent class analysis to identify preference segments and estimate potential reach. Aim 3 integrates preference-based uptake from Aim 2 with Aim 1 efficacy and cost inputs in a mathematical model to estimate health impact, QALYs, net QALYs, and incremental cost-effectiveness across heterogeneous populations and Ending the HIV Epidemic jurisdictions. Innovation lies in linking cure R&D horizons to end-user preferences and transmission-dynamic outcomes, an approach that anticipates real-world use rather than retrofitting after approval. Deliverables include ranked cure attributes for product optimization, uptake projections including among unsuppressed PWH, and jurisdiction-specific value assessments to guide public health investment. By aligning cure design with what patients will accept and systems can sustain, REALISE will accelerate effective deployment of future cure strategies and maximize their contribution to Ending the HIV Epidemic. In doing so, this study advances NIH's priorities by connecting implementation science with prevention, treatment, and cure research. Using a multidisciplinary strategy to refine and extend `target product profiles,' REALISE will ensure cure development reflects patient needs and accelerate translation into real-world benefit.

Causal mechanisms driving germline predisposition to myeloproliferative disorders

SUMMARY/ABSTRACT Although human genetic studies have indicated a significant hereditary predisposition to myeloproliferative neoplasms (MPNs) the underlying mechanisms driving the genetic risk remains unknown. Our large genome wide association study (GWAS) on MPNs identified several non-coding genetic risk loci associated with disease and implicated modulation of hematopoietic stem cell (HSC) self-renewal by the genetic variants. The long-term goal is to utilize our GWAS results to better understand MPN disease initiation and progression and draw out key unknown MPN predisposition genes. The overall objectives in this application are to elucidate the mechanisms by which MPN risk variants promote disease initiation and progression. The central hypothesis is that common genetic variants increase MPN risk by affecting regulatory elements that influence clonal expansion of HSCs carrying MPN driver mutations. The rationale for this project is that the HSC clones with most prevalent driver mutation found in MPN, JAK2V617F show individual specific growth rates and can develop into MPN or remain as clonal hematopoiesis without any consequences indicating that germline genetic factors influence this process. The central hypothesis will be tested by pursuing two specific aims: 1) To determine the mechanisms by which genetic variation at the GFI1B locus influences MPN predisposition in vivo. 2) To define upstream transcriptional mechanisms disrupted by common genetic variants that predispose to MPN. Under the first aim, a newly generated mouse model will be used to evaluate clonal expansion of JAK2V617F HSCs in the context of a germline Gfi1b enhancer deletion by in vivo competitive transplantation assays. The murine studies will be complemented by an assessment of Gfi1b allele specific clonal expansion in primary human hematopoietic stem and progenitor cells (HSPCs) engineered to carry JAK2V617F mutation. Mechanistically activated mitochondrial respiration will be examined in germline enhancer inactivated JAK2V617F HSPCs in murine models and human patient samples. For the second aim, perturbation of RUNX1 bound cis-regulatory elements by MPN risk variants will be evaluated as a mechanism of clonal expansion in MPN by using lentiviral reporter assays and endogenous CRISPR/Cas9 editing approaches in primary human HSPCs and degron tagged RUNX1 cell lines. A Runx1 haploinsufficiency mouse model will be used to assess global influences of RUNX1 transcriptional network on MPN initiation. Collectively, our proposed studies aim to bridge the gap between inherited genetic variations and the clonal expansion dynamics of MPN stem cells, shedding light on crucial factors influencing disease development. The mouse models proposed in this study provide the in vivo physiological context and functional readouts required to investigate HSC clonal expansion and MPN pathogenesis.

NeuroASCENT- Advancing Science through Career Enhancement and Neuroscience Training

The NeuroASCENT- Advancing Science through Career Enhancement and Neuroscience Training program will support neuroscience‑focused PhD students across multiple graduate programs by providing comprehensive scientific, professional, and research‑development training during their doctoral education. Strengthening the national neuroscience workforce requires ensuring that trainees have access to high‑quality research preparation, strong mentoring, and structured opportunities that enhance their scientific growth and career readiness. Recent analyses of U.S. doctoral recipients indicate that many talented trainees encounter barriers that limit full participation in research careers, underscoring the need for intentional support mechanisms that promote successful advancement. Over the last five years, CU Anschutz PhD programs have seen a substantial increase in students entering from a broad range of academic backgrounds. NeuroASCENT is designed to help these trainees progress efficiently by 1) promoting research excellence, 2) fostering leadership skills, 3) facilitating career development, and 4) providing individualized guidance. To achieve these goals, the program will provide career‑focused workshops, structured research externship opportunities, enhanced mentoring frameworks, and coordinated access to campus resources that extend beyond those offered by individual graduate programs. In partnership with the Office of Research Education, NeuroASCENT will complement and enhance the scientific training provided across biomedical PhD programs while offering added value to the broader CU Anschutz graduate community. Program Directors Dr. Quillinan and Dr. Hughes will oversee training activities, mentor matching, evaluation, program operations, and dissemination. An Institutional Advisory Board composed of research leaders will guide program oversight, and an External Advisory Board of graduate‑education experts will provide additional evaluation and strategic input. NeuroASCENT scholars will also serve on an Executive Advisory Board to develop leadership experience and contribute directly to program refinement. Trainees will typically enter the program after their second year of graduate training and will participate in activities focused on building a supportive peer/mentor network, strengthening scientific confidence and competence, and preparing for careers in academia, government, industry, or non‑profit research organizations.

Neuroinflammation in Cerebral Small Vessel Disease

Project Summary/Abstract Cerebral small vessel disease (cSVD) is a leading cause of vascular contributions to cognitive impairment and dementia (VCID), which is the 2nd leading cause of dementia and a significant contributor to Alzheimer’s disease (AD). Thus far, the underlying pathogenesis of cSVD is poorly understood. Several lines of evidence, including animal models, postmortem human brain pathology, and systemic inflammatory markers, demonstrated the damaging role of chronic neuroinflammation in cSVD. Direct evidence of neuroinflammation at the tissue level in patients with cSVD is still critically needed. The sphingosine-1-phosphate receptor 1 (S1PR1) regulates neuroinflammation through microglial and astrocyte activation and trafficking and has emerged as a promising target for neuroinflammation. In postmortem brains of patients with cSVD, we observed elevated S1PR1 expression and colocalization of S1PR1 with astrocytes and microglia. A novel 11C-CS1P1 PET radiotracer with high affinity and specificity targeting S1PR1 has been recently developed and validated in animal models and post-mortem human specimens. Under an FDA-approved eIND (IND 146548), we have successfully completed the safety and dosimetry study in healthy participants and performed preliminary studies in patients with cSVD. We found that 11C-CS1P1 PET uptake is significantly associated with WMH lesion burden in patients with cSVD after controlling for age, sex, race, vascular risk factors, and amyloid deposition. We hypothesize that 11C-CS1P1 PET uptake is a tissue-level biomarker of neuroinflammation to provide insight into cSVD severity, progression, and prognosis. We will 1) evaluate the relationship between 11C-CS1P1 PET uptake and cSVD neuroimaging abnormalities and cognitive impairment, 2) evaluate the test-retest repeatability and longitudinal evolution, and 3) determine whether 11C-CS1P1 PET uptake at baseline predict cSVD progression. The successful completion of this study will establish 11C-CS1P1 PET as an neuroinflammation imaging biomarker and investigate the role of neuroinflammation in cSVD pathogenesis and progression. It will lay a foundation for developing future therapies in modulating neuroinflammation.

Utilizing integrin-targeted PET imaging and therapeutics to predict and treat radiation-induced pulmonary fibrosis

Project Summary/Abstract. Lung cancer is the leading cause of cancer death in the US, with over 125,000 deaths annually. Radiation therapy (RT) is a critical component of curative lung cancer treatment for many patients. However, radiationinduced pulmonary fibrosis (RIPF) is a common side effect that carries a poor prognosis with limited treatment options. Up to 40% of patients with lung cancer who receive RT may experience RIPF. RIPF is a late effect of RT, typically occurring 3 or more months after treatment. The symptoms of RIPF can include shortness of breath, pleural effusions, decreased lung function, and respiratory failure. Cell surface integrin heterodimers play a key role in the pathogenesis of RIPF. In particular, the integrin αvβ6, which is expressed at a low level in the alveolar epithelium at baseline, is significantly upregulated upon RT damage. The key role of integrin αvβ6 in RIPF is illustrated by studies in which mice lacking integrin αvβ6, or treated with an αvβ6-blocking antibody, do not develop RIPF. Here, we propose to translate this mechanistic understanding of RIPF into novel approaches for monitoring and treating RIPF. We hypothesize that non-invasive αvβ6 PET imaging will be safe and can specifically bind to αvβ6 in patients with RIPF. Additionally, we hypothesize that a novel small-molecule integrin antagonist, IDL2965, can mitigate and treat RIPF in mice. In this project, we are utilizing mice to model RIPF, as mice develop RIPF that mimics human disease. In addition, cellular and in vitro models do not approximate the complex biology leading to the development of RIPF. Our data using [64Cu]Cu-DOTA-αvβ6-BP to detect early RIPF in mice are compelling in both single-fraction high-dose RT and lower dose-larger volume RT models (Lo et. al, IJROBP 2025). However, to progress to clinical trials in patients with cancer, we will obtain data to submit an Investigational New Drug (IND) application to the FDA. Importantly, we propose translating [64Cu]Cu-DOTA-αvβ6-BP PET imaging into patients with lung cancer, allowing us to better identify RIPF and develop a tool to determine the efficacy of IDL-2965 in future clinical studies. The specific aims of the proposal are: (1) Characterize the utility of [64Cu]Cu-DOTA-αvβ6-BP in mice with conventionally fractionated RT and identify circulating biomarkers of RIPF, and determine the in vivo toxicology of [64Cu]Cu-DOTA-αvβ6-BP to prepare and submit an exploratory Investigational New Drug (eIND) application to the FDA, (2) Conduct a first-in-human clinical trial of [64Cu]Cu-DOTA-αvβ6-BP to determine its safety and human dosimetry in patients with evidence of RIPF from computed tomography or in healthy controls, and (3) Determine the effect of integrin antagonism using IDL-2965 on mitigating RIPF in preclinical mouse models. The goals of this proposal are two-fold: (1) demonstrate safety and target specificity for [64Cu]Cu-DOTA-αvβ6-BP so that it can be used in future studies to identify RIPF and evaluate the efficacy of anti-fibrotic therapies, and 2) determine the ability of IDL-2965 to prevent RIPF in preclinical mouse models.

Th17 plasticity in rheumatoid arthritis

ABSTRACT The objective of this grant application is to explore the plasticity of Th17 in arthritis. Interleukin-17A (IL-17A) producing Th17 are present in the blood and synovium of patients with rheumatoid arthritis (RA). However, targeting of IL17A has been insufficient to control joint inflammation of RA patients. One potential scenario is that in the context of worsening RA joint inflammation, Th17 undergo conversion into pathogenic IL17A- negative cell populations, collectively called exTh17. The conversion of Th17 into exTh17 has been documented in the context of neuroinflammation, colitis, and infection. However, the occurrence of Th17 plasticity in autoimmune arthritis and its potential role in perpetuating synovial inflammation has remained mostly unexplored. We generated a novel fate-mapping mouse model of autoimmune arthritis, which allows to follow the conversion of Th17 into exTh17, and collected preliminary data suggesting that Th17 undergo significant loss of IL17A expression and conversion into exTh17 in the context of synovial inflammation. We also identified exTh17 signatures which might help exTh17 perpetuate joint inflammation despite their loss of IL17A expression. Here our objective is to further elucidate intrinsic (Aim 1) and extrinsic (Aim 2) mechanism of Th17-exTh17 conversion and exTh17-mediated joint inflammation, and explore the potential role of exTh17 in RA interstitial lung disease (ILD, Aim 3) a feared and often untreatable complication of established RA. Our long-term goal is to leverage the knowledge of local immune cell phenotypes and how they change at various stages of disease to enable stage-specific and personalized therapies of RA which minimize non- specific immunosuppression.

Circadian regulation of reperfusion efficacy in acute ischemic stroke

Reperfusion with thrombectomy has changed the clinical landscape for ischemic stroke. Recently, some studies suggest that patients with “large cores” may still benefit from reperfusion. Why? If these “cores” represent dead brain, why should reperfusion help? One logical explanation is that currently used neuroimaging “cores”, do not always identify uniformly dead tissue. Our pilot data suggest that these “cores” include tissue with a wide range of injury, indicated as changes in relative CT Hounsfield Units (rHU). Importantly, circadian mechanisms may be involved. Ischemic tissue with less severe changes in rHU tend to occur in the morning (active phase) when responses to reperfusion are better. In mouse models of stroke, ischemic injury is also less severe when strokes occur during the nighttime (active phase for nocturnal animals). In contrast, more severe ischemic injury during the daytime (inactive phase for mice) is accompanied by dampened vasodilation and CBF response along with increased immunothrombosis and neutrophil extracellular traps (NETosis). Is it possible that understanding these circadian mechanisms may help identify patients who respond best to reperfusion? And is it possible that targeting these circadian mechanisms can help convert non- responders into responders? In this multi-PI project, we use a translational approach (clinical neuroimaging and biomarkers in stroke patients, mouse models of stroke, CT-PET imaging of tissue viability, molecular pharmacology) with three integrated aims that can be pursued in parallel. Aim 1 will use neuroimaging in stroke patients to show that less severe rHU values in reperfusion-responsive “cores” tend to occur in the morning, whereas more severe rHU values in reperfusion-non-responsive “cores” occur later. Aim 2 will use clinical biomarkers to show that more severe rHU “cores” that are not reperfusion-responsive correlate with circadian effects on vasodilation and immunothrombosis. Aim 3 will use mouse stroke models to test whether targeting these circadian mechanisms of vasodilation and immunothrombosis can convert reperfusion-non-responders into reperfusion-responders. Patients cannot choose when they have a stroke. So why should we pay attention to circadian mechanisms? There may be 2 reasons that are addressed by the present project. First, thrombectomy is resource-intensive, and in spite of the very low number-needed-to-treat, only 20% of “large core” patients do well after reperfusion. Our studies may help identify who (when) these responders are. Second, the pathophysiologic mechanisms of cerebral ischemia differ depending on time-of-day. Therefore, understanding and then targeting these circadian mechanisms may allow us to convert reperfusion non-responders into responders.

Characterization and functional impact of somatic numtogenesis in the human cortex

Project Summary This project focuses on studying nuclear mitochondrial insertions (numts), which are fragments of mitochondrial DNA that get integrated into the nuclear DNA of human cells. While this process, called numtogenesis, occurs naturally and can be passed down to future generations, it has also been observed to occur somatically in our bodies. Historically the function of numts has been difficult to study because they are repetitive and difficult to map with short read sequencing technologies, but there is emerging evidence that they can influence cell function and play a role in diseases, aging, and even complicate genetic studies. Our recent research discovered numts in the human brain’s cortex, and their presence appeared to be linked with earlier death, suggesting they may play a role in aging. However, due to limitations in the data we used, we could not fully explore the extent or impact of these insertions across different tissues or individuals. This project aims to map and study numts in more detail, especially in the human cortex, to further explore this ongoing transfer of DNA from the mitochondria to the nuclear genome and their potential to impact aging and brain function. We will accomplish this by 1) improving sequencing methods to detect numts, 2) comparing their presence across different tissues, and 3) investigating how they affect gene expression and DNA structure. By the end of the project, we aim to provide a model for how such somatic variation may occur and impact cellular function at the tissue level.

Effects of Apolipoprotein A4 on Lipid Metabolism via Sympathetic Regulation

Obesity increases the risks and progression of hypertriglyceridemia, metabolic dysfunction- associated steatotic liver disease (MASLD), and cardiovascular diseases. Previous studies demonstrate that a single injection of apolipoprotein A4 (APOA4) elevates sympathetic neural activity and fatty acid β-oxidation in adipose tissues; and consistent infusion of APOA4 in obese mice fed a high-fat diet lowers fat mass, reduces hypertriglyceridemia, elevates brown adipose tissue thermogenesis, and attenuates steatosis and enhances sympathetic neural activity in the liver. This project hypothesizes that APOA4 reduces hypertriglyceridemia by regulating lipid metabolism through sympathetic stimulation in adipose tissues (Specific Aim 1) and sympathetic action in the liver (Specific Aim 2). The role of sympathetic action via the neurotransmitter norepinephrine and adrenergic receptor-mediated pathways will be investigated, and their necessity in APOA4-mediated lipid metabolism will be tested. A strength of this project is the interdisciplinary collaboration between investigators with established successful collaboration and publications. The project will provide physiological, molecular, and neurochemical mechanisms underlying how APOA4 differentially regulates metabolism through sympathetic activation in various types of adipose tissues and the liver in male and female obese mice. Findings would provide impetus to develop unique, novel, targeted therapeutic applications against hypertriglyceridemia and MASLD. Importantly, this project will expose undergraduates and graduate students to meritorious research, provide students with hands-on biomedical research experience, and strengthen research environment at R15 eligible institutions.

Autoreactive T cells in lupus

The autoimmune disease systemic lupus erythematosus (SLE) is characterized by loss of adaptive immune tolerance in conjunction with innate immune system hyperactivity. Autoantibodies, produced by plasma cells derived from activated B cells, form proinflammatory immune complexes. These immune complexes drive feed forward loops that sustain a systemic inflammatory environment and deposit in tissues leading to potentially fatal organ damage. B cells receive help from T cells to produce antibodies. They also contribute to disease by shaping T cell responses and secreting cytokines. Recent case reports in which SLE patients were treated with anti-CD19 CAR-T cell therapy to deplete B cells highlight the pathogenic role of B cells in lupus and their value as a therapeutic target. However, a better understanding of how autoreactive B cells interact with autoreactive T cells may reveal more targeted points of therapeutic intervention that specifically block autoreactive responses while sparing protective ones. Antigen specific interactions between CD4+ T cells and B cells are required for the development of autoimmune disease in lupus. However, whether these critical interactions occur in germinal centers, where competition for CD4+ T cell help selects high affinity B cells, or in extrafollicular responses, where B cells may avoid peripheral tolerance checkpoints, is unclear. Gene expression profiles and pathways specific to autoreactive CD4+ T cells, and how they are shaped by their interaction with autoreactive B cells, are also ill defined. CD8+ T cells, which recognize antigen presented on MHC Class I, have also been suggested to modulate the fate of autoreactive B cells. They can directly kill autoreactive B cells as a means of tolerance, and a subset of CD8+ T cells has recently been shown to have B cell helper function. Whether and how such interactions between B and CD8+ T cells enhance or suppress the development of lupus is unknown. Here, we will use genetic and in vivo proximity labeling approaches to address these knowledge gaps. In Aim 1, we will test the hypothesis that antigen specific interactions between B and CD8+ T cells promote B cell activation and autoantibody production in lupus. We will prevent B cells, but not other cells, from undergoing cognate interactions with CD8+ T cells via B cell-specific deletion of B2M, a component of the MHC Class I complex, in two lupus models. In Aim 2, will use the uLIPSTIC in vivo proximity system to label all T cells interacting with B cells in lupus models compared to wild type controls. Features specific to these autoreactive T cells will be defined by flow cytometry, scRNA Seq, and scTCR-Seq. These studies will provide valuable molecular and cellular insight into the mutual activation of B and T cells in lupus. They will set the stage for future mechanistic studies defining the role of autoreactive T cell specific genes and pathways and potentially highlight new therapeutic targets specific to autoreactive B/T interactions.

Structure-Based Development of Nucleotide-Competing Inhibitors Against HIV-1 and LINE-1 Reverse Transcriptases

PROJECT SUMMARY Reverse transcriptases (RTs) from retroviruses and endogenous retroelements are essential polymerases that catalyze RNA- and DNA-dependent DNA synthesis. Nucleoside inhibitors (NIs) remain central to HIV-1 therapy and are also used against other viral infections and in cancer, but toxicity, limited selectivity, pharmacokinetic (PK) liabilities, and the emergence of drug resistance highlight the need for alternative RT inhibitor mechanisms. In contrast to NIs, nucleotide-competing inhibitors (NCIs) block the polymerase active site without requiring incorporation into nucleic acids. Structural studies by PI Ruiz have defined the NCI mechanism of action for HIV- 1 RT and revealed conserved binding modules shared across multiple polymerase families. These advances now enable rational discovery of improved NCIs. LINE-1 (L1) ORF2 RT is an emerging therapeutic target in cancer, autoimmunity, and aging, yet NIs are the only inhibitors known to act against L1 RT. Notably, the NCI-binding region is structurally similar between HIV-1 RT and L1 RT, suggesting that NCI recognition principles may extend across these two biologically distinct polymerases. This R21 seeks to establish proof-of-concept for NCI development against both enzymes. Aim 1 will discover and structurally optimize NCIs targeting HIV-1 RT by combining binding modules from known NCI chemotypes and determining their biochemical activity and co-crystal structures. Aim 2 will determine whether HIV-1 RT NCI principles translate to L1 RT by solving L1 RT/nucleic acid/NCI structures, evaluating enzymatic inhibition, and applying AI-based structure prediction and generative design to propose L1-specific NCI candidates. Cellular retrotransposition assays will test mechanism of action. Aim 3 will develop a fragment library tailored to protein–nucleic acid interfaces and perform fragment screening of HIV-1 and L1 RT/nucleic acid complexes to identify additional chemotypes that engage the NCI binding region. Successful completion will yield NCI scaffolds and mechanistic insights applicable to HIV-1 RT and L1 RT, define structural principles governing NCI recognition across two evolutionarily related polymerases, and establish new avenues for RT inhibitor development. The PI is highly qualified to lead this work, with extensive expertise in RT structural biology, drug design, and fragment-based discovery.

Targeted Prodrug Cytokines for Metastatic Breast Cancer Immunotherapy

Project Summary. Our approach directly addresses key limitations in targeting and treating metastatic breast cancer, where we propose the selective activation of modular immune-modulating cytokines within the hypoxic and ROS-active TME for delivery across the BBB, providing the necessary pre-clinical data for future clinical translation. The in vitro and in vivo investigations of this novel immunotherapeutic in immunocompetent models will allow our team to study the interplay between tumor-driven immune activation, cytokine signaling, and anti-tumor immunity in both primary and metastatic sites, and establish a robust groundwork for subsequent clinical validation within the OSUCCC. This proposal addresses two key challenges in developing a novel immunotherapy strategy for breast cancer by answering two hypotheses: (1) can a modular immunotherapy platform with tumor-selective activation of prodrug recombinant cytokines overcome these limitations in drug delivery, and (2) can the development of nanobody-cytokine fusions that can selectively target primary breast cancer tumors and cross the BBB to reach metastatic tumor sites? The first hypothesis focuses on achieving tumor environment-specific activation of prodrug-based recombinant cytokines. Protein cytokines are highly potent, and while others have tried to block their activity using a fused genetic linker to ‘mask’ functionality, no one has yet attempted to use a non-canonical-based chemical strategy to achieve this inhibition. Immune-modulating cytokines will be recombinantly expressed with integrated ncAAs that block cytokine activity until the function is regenerated in the breast cancer TME. Once the cytokine activity is controlled, our second hypothesis will be to achieve selective delivery of the cytokine via fusion to nanobodies. While success has been found in targeting primary tumors in drug and protein delivery, a key challenge remains in reaching secondary metastatic tumors in hard-to-reach sites (i.e., brain). Engineered nanobodies, with affinity for breast cancer tumors and the ability to bind to BBB transcytosis receptors, will enable selective delivery to metastatic breast-to-brain tumors, resulting in tumor- specific activation, immune responses, and improved therapeutic outcomes. This system can significantly improve therapeutic outcomes for patients with mBC by integrating selective activation and delivery mechanisms to reduce off-target effects and enhance tumor-specific immune responses in both primary and secondary metastatic tumor sites. Optimizing drug delivery systems to tune immune responses could offer more effective and less invasive treatment options when compared to traditional and engineered cell-based approaches. Our momentum towards precision medicine and targeted therapies holds significant promise for improving outcomes for mBC patients, and has the potential to serve as a pan-cancer treatment for aggressive metastatic cancers from the following aims: (1) generating a modular platform for tumor-specific activation of prodrug cytokines, (2) evaluating cytokine delivery and anti-cancer immune phenotypes in mBC.

Development of a synthetic human centromere

PROJECT SUMMARY/ABSTRACT Human artificial chromosomes (HACs) are mini-chromosomes that can be stably inherited across many cellular generation. HACs are potentially powerful gene therapy vectors and extremely useful tools in biological research. The stability of HACs depends on the presence of a functional centromere. Centromeres are unique genomic loci that mediate the segregation of chromosomes during mitosis by forming kinetochores leading to microtubule attachment. These sites are specified by the incorporation of distinct nucleosomes in which histone H3 is replaced by CENP- A. Most centromeric nucleosomes are embedded in highly repetitive alpha-satellite DNA. The current versions of the HACs contain alpha-satellite centromeric DNA, are relatively inefficient and frequently recombine into the genome. Despite the presence of alpha-satellite DNA at centromeres, it is not absolutely required for centromere function. This is evidenced by the existence of neocentromeres in some people, and work from our lab and others that centromeres can be induced to form at non-centromeric sites. Deposition of centromeric nucleosomes is mediated by the CENP-A specific chaperone HJURP and the Mis18 complex. Previous work has shown that artificially targeting HJURP and Mis18 proteins to LacO arrays can create de novo centromeres at non-centromeric sites. This approach leads to the formation of a full centromere, recapitulating most of the characteristics of an endogenous centromere. Here we propose to develop a more versatile approach which can be re-programmed to target many different sequences. This powerful approach will provide new and exciting insight into the rules of centromere formation. The proposal will explore the practical application of de novo centromere formation in supporting the stability of human artificial chromosomes (HACs). We will test if these synthetic centromeres (SynCen) can lead to stable inheritance of a human artificial chromosome. More efficient stable non-repetitive synthetic centromere will greatly expand the potential use of HACs as gene therapy vectors.

Facilitating the Advancement of Research and Education for Undergraduate Students by Incorporating Laser Scanning Confocal Microscopy (FAREUS-LSCM)

PROJECT SUMMARY/ABSTRACT The University of Puerto Rico at Aguadilla (UPR-Aguadilla) requests funding to acquire a Nikon AX Galvo Confocal Laser Scanning Microscope (LSCM) with a TI2-E inverted platform and a four- laser configuration (405/488/561/640 nm) to establish transformative imaging capabilities at our resource-limited institution serving 96% Pell Grant recipients. This state-of-the-art instrument addresses a critical infrastructure gap, enabling high-resolution fluorescence imaging, live-cell microscopy, and quantitative analysis essential for competitive biomedical research and undergraduate education. The LSCM will directly support four active research projects spanning parasitology (monogenean host-specificity studies), plant pathology (coffee biocontrol development), environmental chemistry (metalloprotein biomarkers), and neuroscience (astrocyte dysfunction in diabetic epilepsy) while integrating into core laboratory courses including Immunology (BIOL 4009) and Undergraduate research courses (BIOL 3108 and QUIM 4999). Our multidisciplinary faculty, in partnership with the Neuroimaging and Electrophysiology Facility (NIEF) Excellence Imaging Center, offers expertise in confocal microscopy, encompassing advanced imaging and specialized sample preparation techniques. This collaboration ensures effective implementation of the technology, sustained technical support, and high-quality training programs that will enhance research productivity and broaden educational impact. The broad, long-term objective is to transform UPR-Aguadilla from a primarily teaching institution into a research-active campus capable of producing graduate-school-ready students equipped with cutting-edge technical skills. Access to advanced confocal microscopy will stimulate new research collaborations, enhance faculty productivity, and provide 30-40 students annually with hands-on experience in modern imaging technologies currently absent from our curriculum. The instrument will strengthen our partnership with the emerging Natural History Museum of Puerto Rico for specimen digitization and support comprehensive outreach programs targeting 25-50 high school students annually through "Seeing Science Up Close" workshops. Expected outcomes include 1- 2 peer-reviewed publications within three years, establishment of 1-2 new institutional collaborations, and measurable enhancement of biomedical research capacity. This investment will significantly advance STEM education and research opportunities at UPR-Aguadilla while expanding access to cutting-edge scientific instrumentation for students pursuing biomedical careers and contributing to the development of skilled researchers in the biomedical sciences.

2026 Thiol-Based Redox Regulation and Signaling Gordon Research Conference and Gordon Research Seminar

PROJECT SUMMARY This proposal requests support for the 10th meeting of the biennial Gordon Research Conference (GRC) and associated Gordon Research Seminar (GRS) on Thiol-Based Redox Regulation and Signaling to be held at the Rey Don Jaime Grand Hotel, Castelldefels, Spain on July 11-12 (GRS) and July 12-17 (GRC), 2026. Regulation of protein function through the post-translational modification of specific cysteine residues (thiol oxidation) plays an important role in cellular adaptation to local and global changes to endogenous and environmental oxidants. A key challenge for the redox-signaling field is to understand how thiol-based signaling mechanisms are integrated into cellular redox homeostasis and how these events facilitate communication between molecules, organelles, cells, and tissues to initiate and coordinate a specialized biological outcome. Significant emphasis for the 2026 meeting will be placed on an exploration of a wider range of cysteine thiol chemistry placed within a cellular context of other, often competing, oxidative or acyl modifications, some of which derive from environmental exposures, and contribute to cancer, aging and the progression of disease. In addition, we will discuss new insights into how cellular redox status impacts metabolic disease and new mathematical and analytical approaches to understand how redox gradients or “waves” impact the spatial and temporal aspects of signaling. A long-term objective is to use this new information to develop diagnostics and therapeutics for a wide range of redox-associated diseases that impact public health. This meeting provides a unique forum for extensive and immersive interaction among chemists, biologists, structural biologists and redox tool-builders, interested in a range of animal and cellular model systems, with clinical researchers and physicians focused on disease processes. While the thematic area of the conference is intentionally broad, its relevance to specialized NIH institutes is highly significant. Not only is redox toxicity proposed as a primary driver of chemically-induced pathology in humans, notably in aging and age-associated diseases, protection from these pathologies by “supersulfides” holds considerable promise. In keeping with the GRC tradition, the 2026 meeting will highlight presentations that emphasize unpublished work, creating a distinctive intellectual experience that enhances the excitement of the meeting. Investigators new to the meeting, junior investigators and graduate and post-graduate trainees will be welcomed. The associated GRS will provide a more intimate forum where graduate and postdoctoral trainees present their research to their peers, while receiving constructive comments from a few senior investigators who serve as mentors. We intend that the GRS/GRC meetings will attract and increase retention of junior scientists in the field of redox biology. We anticipate that the GRC will enhance the education of researchers at all career levels, generate new ideas and collaborations aimed at understanding thiol-based redox regulation and dysfunction, and enable future progress in the prevention, detection, and treatment of a wide-range of human diseases associated with perturbations in redox homeostasis.

Competing Rhythms: Understanding and Modulating Auditory Neural Entrainment

Low intensity rTMS: age dependent effects, and mechanisms underlying neural plasticity

Neuroplasticity is essential for the establishment and strengthening of neural circuits. Repetitive transcranial magnetic stimulation (rTMS) is commonly used to modulate cortical excitability and shows promise in the treatment of some neurological disorders. Low intensity magnetic stimulation (LI-rTMS), which does not directly elicit action potentials in the stimulated neurons, have also shown some therapeutic effects, and it is important to determine the biological mechanisms underlying the effects of these low intensity magnetic fields, such as would occur in the regions surrounding the central high-intensity focus of rTMS. Our team has used a focal low-intensity (10mT) magnetic stimulation approach to address some of these questions and to identify cellular mechanisms. I will present several studies from our laboratory, addressing (1) effects of LIrTMS on neuronal activity and excitability ; and (2) neuronal morphology and post-lesion repair. The ensemble of our results indicate that the effects of LI-rTMS depend upon the stimulation pattern, the age of the animal, and the presence of cellular magnetoreceptors.

Learning and Memory

This webinar on learning and memory features three experts—Nicolas Brunel, Ashok Litwin-Kumar, and Julijana Gjorgieva—who present theoretical and computational approaches to understanding how neural circuits acquire and store information across different scales. Brunel discusses calcium-based plasticity and how standard “Hebbian-like” plasticity rules inferred from in vitro or in vivo datasets constrain synaptic dynamics, aligning with classical observations (e.g., STDP) and explaining how synaptic connectivity shapes memory. Litwin-Kumar explores insights from the fruit fly connectome, emphasizing how the mushroom body—a key site for associative learning—implements a high-dimensional, random representation of sensory features. Convergent dopaminergic inputs gate plasticity, reflecting a high-dimensional “critic” that refines behavior. Feedback loops within the mushroom body further reveal sophisticated interactions between learning signals and action selection. Gjorgieva examines how activity-dependent plasticity rules shape circuitry from the subcellular (e.g., synaptic clustering on dendrites) to the cortical network level. She demonstrates how spontaneous activity during development, Hebbian competition, and inhibitory-excitatory balance collectively establish connectivity motifs responsible for key computations such as response normalization.

Unmotivated bias

In this talk, I will explore how social affective biases arise even in the absence of motivational factors as an emergent outcome of the basic structure of social learning. In several studies, we found that initial negative interactions with some members of a group can cause subsequent avoidance of the entire group, and that this avoidance perpetuates stereotypes. Additional cognitive modeling discovered that approach and avoidance behavior based on biased beliefs not only influences the evaluative (positive or negative) impressions of group members, but also shapes the depth of the cognitive representations available to learn about individuals. In other words, people have richer cognitive representations of members of groups that are not avoided, akin to individualized vs group level categories. I will end presenting a series of multi-agent reinforcement learning simulations that demonstrate the emergence of these social-structural feedback loops in the development and maintenance of affective biases.

Decomposing motivation into value and salience

Humans and other animals approach reward and avoid punishment and pay attention to cues predicting these events. Such motivated behavior thus appears to be guided by value, which directs behavior towards or away from positively or negatively valenced outcomes. Moreover, it is facilitated by (top-down) salience, which enhances attention to behaviorally relevant learned cues predicting the occurrence of valenced outcomes. Using human neuroimaging, we recently separated value (ventral striatum, posterior ventromedial prefrontal cortex) from salience (anterior ventromedial cortex, occipital cortex) in the domain of liquid reward and punishment. Moreover, we investigated potential drivers of learned salience: the probability and uncertainty with which valenced and non-valenced outcomes occur. We find that the brain dissociates valenced from non-valenced probability and uncertainty, which indicates that reinforcement matters for the brain, in addition to information provided by probability and uncertainty alone, regardless of valence. Finally, we assessed learning signals (unsigned prediction errors) that may underpin the acquisition of salience. Particularly the insula appears to be central for this function, encoding a subjective salience prediction error, similarly at the time of positively and negatively valenced outcomes. However, it appears to employ domain-specific time constants, leading to stronger salience signals in the aversive than the appetitive domain at the time of cues. These findings explain why previous research associated the insula with both valence-independent salience processing and with preferential encoding of the aversive domain. More generally, the distinction of value and salience appears to provide a useful framework for capturing the neural basis of motivated behavior.

Neural mechanisms governing the learning and execution of avoidance behavior

The nervous system orchestrates adaptive behaviors by intricately coordinating responses to internal cues and environmental stimuli. This involves integrating sensory input, managing competing motivational states, and drawing on past experiences to anticipate future outcomes. While traditional models attribute this complexity to interactions between the mesocorticolimbic system and hypothalamic centers, the specific nodes of integration have remained elusive. Recent research, including our own, sheds light on the midline thalamus's overlooked role in this process. We propose that the midline thalamus integrates internal states with memory and emotional signals to guide adaptive behaviors. Our investigations into midline thalamic neuronal circuits have provided crucial insights into the neural mechanisms behind flexibility and adaptability. Understanding these processes is essential for deciphering human behavior and conditions marked by impaired motivation and emotional processing. Our research aims to contribute to this understanding, paving the way for targeted interventions and therapies to address such impairments.

The multi-phase plasticity supporting winner effect

Aggression is an innate behavior across animal species. It is essential for competing for food, defending territory, securing mates, and protecting families and oneself. Since initiating an attack requires no explicit learning, the neural circuit underlying aggression is believed to be genetically and developmentally hardwired. Despite being innate, aggression is highly plastic. It is influenced by a wide variety of experiences, particularly winning and losing previous encounters. Numerous studies have shown that winning leads to an increased tendency to fight while losing leads to flight in future encounters. In the talk, I will present our recent findings regarding the neural mechanisms underlying the behavioral changes caused by winning.

Closed-loop deep brain stimulation as a neuroprosthetic of dopaminergic circuits – Current evidence and future opportunities; Spatial filtering to enhance signal processing in invasive neurophysiology

On Thursday February 15th, we will host Victoria Peterson and Julian Neumann. Victoria will tell us about “Spatial filtering to enhance signal processing in invasive neurophysiology”. Besides his scientific presentation on “Closed-loop deep brain stimulation as a neuroprosthetic of dopaminergic circuits – Current evidence and future opportunities”, Julian will give us a glimpse at the person behind the science. The talks will be followed by a shared discussion. Note: The talks will exceptionally be held at 10 ET / 4PM CET. You can register via talks.stimulatingbrains.org to receive the (free) Zoom link!

Using Adversarial Collaboration to Harness Collective Intelligence

There are many mysteries in the universe. One of the most significant, often considered the final frontier in science, is understanding how our subjective experience, or consciousness, emerges from the collective action of neurons in biological systems. While substantial progress has been made over the past decades, a unified and widely accepted explanation of the neural mechanisms underpinning consciousness remains elusive. The field is rife with theories that frequently provide contradictory explanations of the phenomenon. To accelerate progress, we have adopted a new model of science: adversarial collaboration in team science. Our goal is to test theories of consciousness in an adversarial setting. Adversarial collaboration offers a unique way to bolster creativity and rigor in scientific research by merging the expertise of teams with diverse viewpoints. Ideally, we aim to harness collective intelligence, embracing various perspectives, to expedite the uncovering of scientific truths. In this talk, I will highlight the effectiveness (and challenges) of this approach using selected case studies, showcasing its potential to counter biases, challenge traditional viewpoints, and foster innovative thought. Through the joint design of experiments, teams incorporate a competitive aspect, ensuring comprehensive exploration of problems. This method underscores the importance of structured conflict and diversity in propelling scientific advancement and innovation.

Use of brain imaging data to improve prescriptions of psychotropic drugs - Examples of ketamine in depression and antipsychotics in schizophrenia

The use of molecular imaging, particularly PET and SPECT, has significantly transformed the treatment of schizophrenia with antipsychotic drugs since the late 1980s. It has offered insights into the links between drug target engagement, clinical effects, and side effects. A therapeutic window for receptor occupancy is established for antipsychotics, yet there is a divergence of opinions regarding the importance of blood levels, with many downplaying their significance. As a result, the role of therapeutic drug monitoring (TDM) as a personalized therapy tool is often underrated. Since molecular imaging of antipsychotics has focused almost entirely on D2-like dopamine receptors and their potential to control positive symptoms, negative symptoms and cognitive deficits are hardly or not at all investigated. Alternative methods have been introduced, i.e. to investigate the correlation between approximated receptor occupancies from blood levels and cognitive measures. Within the domain of antidepressants, and specifically regarding ketamine's efficacy in depression treatment, there is limited comprehension of the association between plasma concentrations and target engagement. The measurement of AMPA receptors in the human brain has added a new level of comprehension regarding ketamine's antidepressant effects. To ensure precise prescription of psychotropic drugs, it is vital to have a nuanced understanding of how molecular and clinical effects interact. Clinician scientists are assigned with the task of integrating these indispensable pharmacological insights into practice, thereby ensuring a rational and effective approach to the treatment of mental health disorders, signaling a new era of personalized drug therapy mechanisms that promote neuronal plasticity not only under pathological conditions, but also in the healthy aging brain.

Algonauts 2023 winning paper journal club (fMRI encoding models)

Algonauts 2023 was a challenge to create the best model that predicts fMRI brain activity given a seen image. Huze team dominated the competition and released a preprint detailing their process. This journal club meeting will involve open discussion of the paper with Q/A with Huze. Paper: https://arxiv.org/pdf/2308.01175.pdf Related paper also from Huze that we can discuss: https://arxiv.org/pdf/2307.14021.pdf

Immunosuppression for Parkinson's disease - a new therapeutic strategy?

Caroline Williams-Gray is a Principal Research Associate in the Department of Clinical Neurosciences, University of Cambridge, and an honorary consultant neurologist specializing in Parkinson’s disease and movement disorders. She leads a translational research group investigating the clinical and biological heterogeneity of PD, with the ultimate goal of developing more targeted therapies for different Parkinson’s subtypes. Her recent work has focused on the theory that the immune system plays a significant role in mediating the heterogeneity of PD and its progression. Her lab is investigating this using blood and CSF -based immune markers, PET neuroimaging and neuropathology in stratified PD cohorts; and she is leading the first randomized controlled trial repurposing a peripheral immunosuppressive drug (azathioprine) to slow the progression of PD.

Euclidean coordinates are the wrong prior for primate vision

The mapping from the visual field to V1 can be approximated by a log-polar transform. In this domain, scale is a left-right shift, and rotation is an up-down shift. When fed into a standard shift-invariant convolutional network, this provides scale and rotation invariance. However, translation invariance is lost. In our model, this is compensated for by multiple fixations on an object. Due to the high concentration of cones in the fovea with the dropoff of resolution in the periphery, fully 10 degrees of visual angle take up about half of V1, with the remaining 170 degrees (or so) taking up the other half. This layout provides the basis for the central and peripheral pathways. Simulations with this model closely match human performance in scene classification, and competition between the pathways leads to the peripheral pathway being used for this task. Remarkably, in spite of the property of rotation invariance, this model can explain the inverted face effect. We suggest that the standard method of using image coordinates is the wrong prior for models of primate vision.

Estimating repetitive spatiotemporal patterns from resting-state brain activity data

Repetitive spatiotemporal patterns in resting-state brain activities have been widely observed in various species and regions, such as rat and cat visual cortices. Since they resemble the preceding brain activities during tasks, they are assumed to reflect past experiences embedded in neuronal circuits. Moreover, spatiotemporal patterns involving whole-brain activities may also reflect a process that integrates information distributed over the entire brain, such as motor and visual information. Therefore, revealing such patterns may elucidate how the information is integrated to generate consciousness. In this talk, I will introduce our proposed method to estimate repetitive spatiotemporal patterns from resting-state brain activity data and show the spatiotemporal patterns estimated from human resting-state magnetoencephalography (MEG) and electroencephalography (EEG) data. Our analyses suggest that the patterns involved whole-brain propagating activities that reflected a process to integrate the information distributed over frequencies and networks. I will also introduce our current attempt to reveal signal flows and their roles in the spatiotemporal patterns using a big dataset. - Takeda et al., Estimating repetitive spatiotemporal patterns from resting-state brain activity data. NeuroImage (2016); 133:251-65. - Takeda et al., Whole-brain propagating patterns in human resting-state brain activities. NeuroImage (2021); 245:118711.

Integrative Neuromodulation: from biomarker identification to optimizing neuromodulation

Why do we make decisions impulsively blinded in an emotionally rash moment? Or caught in the same repetitive suboptimal loop, avoiding fears or rushing headlong towards illusory rewards? These cognitive constructs underlying self-control and compulsive behaviours and their influence by emotion or incentives are relevant dimensionally across healthy individuals and hijacked across disorders of addiction, compulsivity and mood. My lab focuses on identifying theory-driven modifiable biomarkers focusing on these cognitive constructs with the ultimate goal to optimize and develop novel means of neuromodulation. Here I will provide a few examples of my group’s recent work to illustrate this approach. I describe a series of recent studies on intracranial physiology and acute stimulation focusing on risk taking and emotional processing. This talk highlights the subthalamic nucleus, a common target for deep brain stimulation for Parkinson’s disease and obsessive-compulsive disorder. I further describe recent translational work in non-invasive neuromodulation. Together these examples illustrate the approach of the lab highlighting modifiable biomarkers and optimizing neuromodulation.

Multisensory processing of anticipatory and consummatory food cues

Can a single neuron solve MNIST? Neural computation of machine learning tasks emerges from the interaction of dendritic properties

Physiological experiments have highlighted how the dendrites of biological neurons can nonlinearly process distributed synaptic inputs. However, it is unclear how qualitative aspects of a dendritic tree, such as its branched morphology, its repetition of presynaptic inputs, voltage-gated ion channels, electrical properties and complex synapses, determine neural computation beyond this apparent nonlinearity. While it has been speculated that the dendritic tree of a neuron can be seen as a multi-layer neural network and it has been shown that such an architecture could be computationally strong, we do not know if that computational strength is preserved under these qualitative biological constraints. Here we simulate multi-layer neural network models of dendritic computation with and without these constraints. We find that dendritic model performance on interesting machine learning tasks is not hurt by most of these constraints and may synergistically benefit from all of them combined. Our results suggest that single real dendritic trees may be able to learn a surprisingly broad range of tasks through the emergent capabilities afforded by their properties.

Gut food cravings? How gut signals control appetite and metabolism

Gut-derived signals regulate metabolism, appetite, and behaviors important for mental health. We have performed a large-scale multidimensional screen to identify gut hormones and nutrient-sensing mechanisms in the intestine that regulate metabolism and behavior in the fruit fly Drosophila. We identified several gut hormones that affect fecundity, stress responses, metabolism, feeding, and sleep behaviors, many of which seem to act sex-specifically. We show that in response to nutrient intake, the enteroendocrine cells (EECs) of the adult Drosophila midgut release hormones that act via inter-organ relays to coordinate metabolism and feeding decisions. These findings suggest that crosstalk between the gut and other tissues regulates food choice according to metabolic needs, providing insight into how that intestine processes nutritional inputs and into the gut-derived signals that relay information regulating nutrient-specific hungers to maintain metabolic homeostasis.

Training Dynamic Spiking Neural Network via Forward Propagation Through Time

With recent advances in learning algorithms, recurrent networks of spiking neurons are achieving performance competitive with standard recurrent neural networks. Still, these learning algorithms are limited to small networks of simple spiking neurons and modest-length temporal sequences, as they impose high memory requirements, have difficulty training complex neuron models, and are incompatible with online learning.Taking inspiration from the concept of Liquid Time-Constant (LTCs), we introduce a novel class of spiking neurons, the Liquid Time-Constant Spiking Neuron (LTC-SN), resulting in functionality similar to the gating operation in LSTMs. We integrate these neurons in SNNs that are trained with FPTT and demonstrate that thus trained LTC-SNNs outperform various SNNs trained with BPTT on long sequences while enabling online learning and drastically reducing memory complexity. We show this for several classical benchmarks that can easily be varied in sequence length, like the Add Task and the DVS-gesture benchmark. We also show how FPTT-trained LTC-SNNs can be applied to large convolutional SNNs, where we demonstrate novel state-of-the-art for online learning in SNNs on a number of standard benchmarks (S-MNIST, R-MNIST, DVS-GESTURE) and also show that large feedforward SNNs can be trained successfully in an online manner to near (Fashion-MNIST, DVS-CIFAR10) or exceeding (PS-MNIST, R-MNIST) state-of-the-art performance as obtained with offline BPTT. Finally, the training and memory efficiency of FPTT enables us to directly train SNNs in an end-to-end manner at network sizes and complexity that was previously infeasible: we demonstrate this by training in an end-to-end fashion the first deep and performant spiking neural network for object localization and recognition. Taken together, we out contribution enable for the first time training large-scale complex spiking neural network architectures online and on long temporal sequences.

Navigating Increasing Levels of Relational Complexity: Perceptual, Analogical, and System Mappings

Relational thinking involves comparing abstract relationships between mental representations that vary in complexity; however, this complexity is rarely made explicit during everyday comparisons. This study explored how people naturally navigate relational complexity and interference using a novel relational match-to-sample (RMTS) task with both minimal and relationally directed instruction to observe changes in performance across three levels of relational complexity: perceptual, analogy, and system mappings. Individual working memory and relational abilities were examined to understand RMTS performance and susceptibility to interfering relational structures. Trials were presented without practice across four blocks and participants received feedback after each attempt to guide learning. Experiment 1 instructed participants to select the target that best matched the sample, while Experiment 2 additionally directed participants’ attention to same and different relations. Participants in Experiment 2 demonstrated improved performance when solving analogical mappings, suggesting that directing attention to relational characteristics affected behavior. Higher performing participants—those above chance performance on the final block of system mappings—solved more analogical RMTS problems and had greater visuospatial working memory, abstraction, verbal analogy, and scene analogy scores compared to lower performers. Lower performers were less dynamic in their performance across blocks and demonstrated negative relationships between analogy and system mapping accuracy, suggesting increased interference between these relational structures. Participant performance on RMTS problems did not change monotonically with relational complexity, suggesting that increases in relational complexity places nonlinear demands on working memory. We argue that competing relational information causes additional interference, especially in individuals with lower executive function abilities.

Chemistry of the adaptive mind: lessons from dopamine

The human brain faces a variety of computational dilemmas, including the flexibility/stability, the speed/accuracy and the labor/leisure tradeoff. I will argue that striatal dopamine is particularly well suited to dynamically regulate these computational tradeoffs depending on constantly changing task demands. This working hypothesis is grounded in evidence from recent studies on learning, motivation and cognitive control in human volunteers, using chemical PET, psychopharmacology, and/or fMRI. These studies also begin to elucidate the mechanisms underlying the huge variability in catecholaminergic drug effects across different individuals and across different task contexts. For example, I will demonstrate how effects of the most commonly used psychostimulant methylphenidate on learning, Pavlovian and effortful instrumental control depend on fluctuations in current environmental volatility, on individual differences in working memory capacity and on opportunity cost respectively.

PET imaging in brain diseases

Talk 1. PET based biomarkers of treatment efficacy in temporal lobe epilepsy A critical aspect of drug development involves identifying robust biomarkers of treatment response for use as surrogate endpoints in clinical trials. However, these biomarkers also have the capacity to inform mechanisms of disease pathogenesis and therapeutic efficacy. In this webinar, Dr Bianca Jupp will report on a series of studies using the GABAA PET ligand, [18F]-Flumazenil, to establish biomarkers of treatment response to a novel therapeutic for temporal lobe epilepsy, identifying affinity at this receptor as a key predictor of treatment outcome. Dr Bianca Jupp is a Research Fellow in the Department of Neuroscience, Monash University and Lead PET/CT Scientist at the Alfred Research Alliance–Monash Biomedical Imaging facility. Her research focuses on neuroimaging and its capacity to inform the neurobiology underlying neurological and neuropsychiatric disorders. Talk 2. The development of a PET radiotracer for reparative microglia Imaging of neuroinflammation is currently hindered by the technical limitations associated with TSPO imaging. In this webinar, Dr Lucy Vivash will discuss the development of PET radiotracers that specifically image reparative microglia through targeting the receptor kinase MerTK. This includes medicinal chemistry design and testing, radiochemistry, and in vitro and in vivo testing of lead tracers. Dr Lucy Vivash is a Research Fellow in the Department of Neuroscience, Monash University. Her research focuses on the preclinical development and clinical translation of novel PET radiotracers for the imaging of neurodegenerative diseases.

Growing a world-class precision medicine industry

Monash Biomedical Imaging is part of the new $71.2 million Australian Precision Medicine Enterprise (APME) facility, which will deliver large-scale development and manufacturing of precision medicines and theranostic radiopharmaceuticals for industry and research. A key feature of the APME project is a high-energy cyclotron with multiple production clean rooms, which will be located on the Monash Biomedical Imaging (MBI) site in Clayton. This strategic co-location will facilitate radiochemistry, PET and SPECT research and clinical use of theranostic (therapeutic and diagnostic) radioisotopes produced on-site. In this webinar, MBI’s Professor Gary Egan and Dr Maggie Aulsebrook will explain how the APME will secure Australia’s supply of critical radiopharmaceuticals, build a globally competitive Australian manufacturing hub, and train scientists and engineers for the Australian workforce. They will cover the APME’s state-of-the-art 30 MeV and 18-24 MeV cyclotrons and radiochemistry facilities, as well as the services that will be accessible to students, scientists, clinical researchers, and pharmaceutical companies in Australia and around the world. The APME is a collaboration between Monash University, Global Medical Solutions Australia, and Telix Pharmaceuticals. Professor Gary Egan is Director of Monash Biomedical Imaging, Director of the ARC Centre of Excellence for Integrative Brain Function and a Distinguished Professor at the Turner Institute for Brain and Mental Health, Monash University. He is also lead investigator of the Victorian Biomedical Imaging Capability, and Deputy Director of the Australian National Imaging Facility. Dr Maggie Aulsebrook obtained her PhD in Chemistry at Monash University and specialises in the development and clinical translation of radiopharmaceuticals. She has led the development of several investigational radiopharmaceuticals for first-in-human application. Maggie leads the Radiochemistry Platform at Monash Biomedical Imaging.

The neural basis of flexible semantic cognition (BACN Mid-career Prize Lecture 2022)

Semantic cognition brings meaning to our world – it allows us to make sense of what we see and hear, and to produce adaptive thoughts and behaviour. Since we have a wealth of information about any given concept, our store of knowledge is not sufficient for successful semantic cognition; we also need mechanisms that can steer the information that we retrieve so it suits the context or our current goals. This talk traces the neural networks that underpin this flexibility in semantic cognition. It draws on evidence from multiple methods (neuropsychology, neuroimaging, neural stimulation) to show that two interacting heteromodal networks underpin different aspects of flexibility. Regions including anterior temporal cortex and left angular gyrus respond more strongly when semantic retrieval follows highly-related concepts or multiple convergent cues; the multivariate responses in these regions correspond to context-dependent aspects of meaning. A second network centred on left inferior frontal gyrus and left posterior middle temporal gyrus is associated with controlled semantic retrieval, responding more strongly when weak associations are required or there is more competition between concepts. This semantic control network is linked to creativity and also captures context-dependent aspects of meaning; however, this network specifically shows more similar multivariate responses across trials when association strength is weak, reflecting a common controlled retrieval state when more unusual associations are the focus. Evidence from neuropsychology, fMRI and TMS suggests that this semantic control network is distinct from multiple-demand cortex which supports executive control across domains, although challenging semantic tasks recruit both networks. The semantic control network is juxtaposed between regions of default mode network that might be sufficient for the retrieval of strong semantic relationships and multiple-demand regions in the left hemisphere, suggesting that the large-scale organisation of flexible semantic cognition can be understood in terms of cortical gradients that capture systematic functional transitions that are repeated in temporal, parietal and frontal cortex.

Synthetic and natural images unlock the power of recurrency in primary visual cortex

During perception the visual system integrates current sensory evidence with previously acquired knowledge of the visual world. Presumably this computation relies on internal recurrent interactions. We record populations of neurons from the primary visual cortex of cats and macaque monkeys and find evidence for adaptive internal responses to structured stimulation that change on both slow and fast timescales. In the first experiment, we present abstract images, only briefly, a protocol known to produce strong and persistent recurrent responses in the primary visual cortex. We show that repetitive presentations of a large randomized set of images leads to enhanced stimulus encoding on a timescale of minutes to hours. The enhanced encoding preserves the representational details required for image reconstruction and can be detected in post-exposure spontaneous activity. In a second experiment, we show that the encoding of natural scenes across populations of V1 neurons is improved, over a timescale of hundreds of milliseconds, with the allocation of spatial attention. Given the hierarchical organization of the visual cortex, contextual information from the higher levels of the processing hierarchy, reflecting high-level image regularities, can inform the activity in V1 through feedback. We hypothesize that these fast attentional boosts in stimulus encoding rely on recurrent computations that capitalize on the presence of high-level visual features in natural scenes. We design control images dominated by low-level features and show that, in agreement with our hypothesis, the attentional benefits in stimulus encoding vanish. We conclude that, in the visual system, powerful recurrent processes optimize neuronal responses, already at the earliest stages of cortical processing.

Meta-learning synaptic plasticity and memory addressing for continual familiarity detection

Over the course of a lifetime, we process a continual stream of information. Extracted from this stream, memories must be efficiently encoded and stored in an addressable manner for retrieval. To explore potential mechanisms, we consider a familiarity detection task where a subject reports whether an image has been previously encountered. We design a feedforward network endowed with synaptic plasticity and an addressing matrix, meta-learned to optimize familiarity detection over long intervals. We find that anti-Hebbian plasticity leads to better performance than Hebbian and replicates experimental results such as repetition suppression. A combinatorial addressing function emerges, selecting a unique neuron as an index into the synaptic memory matrix for storage or retrieval. Unlike previous models, this network operates continuously, and generalizes to intervals it has not been trained on. Our work suggests a biologically plausible mechanism for continual learning, and demonstrates an effective application of machine learning for neuroscience discovery.

Neural Representations of Social Homeostasis

How does our brain rapidly determine if something is good or bad? How do we know our place within a social group? How do we know how to behave appropriately in dynamic environments with ever-changing conditions? The Tye Lab is interested in understanding how neural circuits important for driving positive and negative motivational valence (seeking pleasure or avoiding punishment) are anatomically, genetically and functionally arranged. We study the neural mechanisms that underlie a wide range of behaviors ranging from learned to innate, including social, feeding, reward-seeking and anxiety-related behaviors. We have also become interested in “social homeostasis” -- how our brains establish a preferred set-point for social contact, and how this maintains stability within a social group. How are these circuits interconnected with one another, and how are competing mechanisms orchestrated on a neural population level? We employ optogenetic, electrophysiological, electrochemical, pharmacological and imaging approaches to probe these circuits during behavior.

Brain and Mind: Who is the Puppet and who the Puppeteer?

If the mind controls the brain, then there is free will and its corollaries, dignity and responsibility. You are king in your skull-sized kingdom and the architect of your destiny. If, on the other hand, the brain controls the mind, an incendiary conclusion follows: There can be no free will, no praise, no punishment and no purgatory. In this webinar, Professor George Paxinos will discuss his highly respected work on the construction of human and experimental animal brain atlases. He has discovered 94 brain regions, 64 homologies and published 58 books. His first book, The Rat Brain in Stereotaxic Coordinates, is the most cited publication in neuroscience and, for three decades, the third most cited book in science. Professor Paxinos will also present his recently published novel, A River Divided, which was 21 years in the making. Neuroscience principles were used in the formation of charters, such as those related to the mind, soul, free will and consciousness. Environmental issues are at the heart of the novel, including the question of whether the brain is the right ‘size’ for survival. Professor Paxinos studied at Berkeley, McGill and Yale and is now Scientia Professor of Medical Sciences at Neuroscience Research Australia and The University of New South Wales in Sydney.

The Brain Conference (the Guarantors of Brain)

Join the Brain Conference on 24-25 February 2022 for the opportunity to hear from neurology’s leading scientists and clinicians. The two-day virtual programme features clinical teaching talks and research presentations from expert speakers including neuroscientist Professor Gina Poe, and the winner of the 2021 Brain Prize, neurologist Professor Peter Goadsby." "Tickets for The Brain Conference 2022 cost just £30, but register with promotional code BRAINCONEM20 for a discounted rate of £25.

The Brain Conference (the Guarantors of Brain)

Join the Brain Conference on 24-25 February 2022 for the opportunity to hear from neurology’s leading scientists and clinicians. The two-day virtual programme features clinical teaching talks and research presentations from expert speakers including neuroscientist Professor Gina Poe, and the winner of the 2021 Brain Prize, neurologist Professor Peter Goadsby." "Tickets for The Brain Conference 2022 cost just £30, but register with promotional code BRAINCONEM20 for a discounted rate of £25.

From bench to clinic – Translating fundamental neuroscience into real-life healthcare practices, and developing nationally recognised life science companies

Dr. Ryan C.N. D’Arcy is a Canadian neuroscientist, researcher, innovator and entrepreneur. Dr. D'Arcy co-founded HealthTech Connex Inc. and serves as President and Chief Scientific Officer. HealthTech Connex translates neuroscience advances into health technology breakthroughs. D'Arcy is most known for coining the term "brain vital signs" and for leading the research and development of the brain vital signs framework. Dr. D’Arcy also holds a BC Leadership Chair in Medical Technology, is a full Professor at Simon Fraser University, and a member of the DM Centre for Brain Health at the University of British Columbia. He has published more than 260 academic works, attracted more than $85 Million CAD in competitive research and innovation funding, and been recognized through numerous awards and distinctions. Please join us for an exciting virtual talk with Dr. D'Arcy who will speak on some of the current research he is involved in, how he is translating this research into real-life applications, and the development of HealthTech Connects Inc.

Brain and Mind: Who is the Puppet and who the Puppeteer?

If the mind controls the brain, then there is FREE WILL and its corollaries, dignity and responsibility. You are king in your skull-sized kingdom and the architect of your destiny. If, on the other hand, the brain controls the mind, an incendiary conclusion follows: There can be no FREE WILL, no praise, no punishment and no purgatory. There will be a presentation of the speaker’s novel which, inter alia, is concerned with this question: 21 year in the making this is the first presentation of A River Divided (environmental genre)

JAK/STAT regulation of the transcriptomic response during epileptogenesis

Temporal lobe epilepsy (TLE) is a progressive disorder mediated by pathological changes in molecular cascades and neural circuit remodeling in the hippocampus resulting in increased susceptibility to spontaneous seizures and cognitive dysfunction. Targeting these cascades could prevent or reverse symptom progression and has the potential to provide viable disease-modifying treatments that could reduce the portion of TLE patients (>30%) not responsive to current medical therapies. Changes in GABA(A) receptor subunit expression have been implicated in the pathogenesis of TLE, and the Janus Kinase/Signal Transducer and Activator of Transcription (JAK/STAT) pathway has been shown to be a key regulator of these changes. The JAK/STAT pathway is known to be involved in inflammation and immunity, and to be critical for neuronal functions such as synaptic plasticity and synaptogenesis. Our laboratories have shown that a STAT3 inhibitor, WP1066, could greatly reduce the number of spontaneous recurrent seizures (SRS) in an animal model of pilocarpine-induced status epilepticus (SE). This suggests promise for JAK/STAT inhibitors as disease-modifying therapies, however, the potential adverse effects of systemic or global CNS pathway inhibition limits their use. Development of more targeted therapeutics will require a detailed understanding of JAK/STAT-induced epileptogenic responses in different cell types. To this end, we have developed a new transgenic line where dimer-dependent STAT3 signaling is functionally knocked out (fKO) by tamoxifen-induced Cre expression specifically in forebrain excitatory neurons (eNs) via the Calcium/Calmodulin Dependent Protein Kinase II alpha (CamK2a) promoter. Most recently, we have demonstrated that STAT3 KO in excitatory neurons (eNSTAT3fKO) markedly reduces the progression of epilepsy (SRS frequency) in the intrahippocampal kainate (IHKA) TLE model and protects mice from kainic acid (KA)-induced memory deficits as assessed by Contextual Fear Conditioning. Using data from bulk hippocampal tissue RNA-sequencing, we further discovered a transcriptomic signature for the IHKA model that contains a substantial number of genes, particularly in synaptic plasticity and inflammatory gene networks, that are down-regulated after KA-induced SE in wild-type but not eNSTAT3fKO mice. Finally, we will review data from other models of brain injury that lead to epilepsy, such as TBI, that implicate activation of the JAK/STAT pathway that may contribute to epilepsy development.

Why would we need Cognitive Science to develop better Collaborative Robots and AI Systems?

While classical industrial robots are mostly designed for repetitive tasks, assistive robots will be challenged by a variety of different tasks in close contact with humans. Hereby, learning through the direct interaction with humans provides a potentially powerful tool for an assistive robot to acquire new skills and to incorporate prior human knowledge during the exploration of novel tasks. Moreover, an intuitive interactive teaching process may allow non-programming experts to contribute to robotic skill learning and may help to increase acceptance of robotic systems in shared workspaces and everyday life. In this talk, I will discuss recent research I did on interactive robot skill learning and the remaining challenges on the route to human-centered teaching of assistive robots. In particular, I will also discuss potential connections and overlap with cognitive science. The presented work covers learning a library of probabilistic movement primitives from human demonstrations, intention aware adaptation of learned skills in shared workspaces, and multi-channel interactive reinforcement learning for sequential tasks.

Wiring Minimization of Deep Neural Networks Reveal Conditions in which Multiple Visuotopic Areas Emerge

The visual system is characterized by multiple mirrored visuotopic maps, with each repetition corresponding to a different visual area. In this work we explore whether such visuotopic organization can emerge as a result of minimizing the total wire length between neurons connected in a deep hierarchical network. Our results show that networks with purely feedforward connectivity typically result in a single visuotopic map, and in certain cases no visuotopic map emerges. However, when we modify the network by introducing lateral connections, with sufficient lateral connectivity among neurons within layers, multiple visuotopic maps emerge, where some connectivity motifs yield mirrored alternations of visuotopic maps–a signature of biological visual system areas. These results demonstrate that different connectivity profiles have different emergent organizations under the minimum total wire length hypothesis, and highlight that characterizing the large-scale spatial organizing of tuning properties in a biological system might also provide insights into the underlying connectivity.

NMC4 Short Talk: Rank similarity filters for computationally-efficient machine learning on high dimensional data

Real world datasets commonly contain nonlinearly separable classes, requiring nonlinear classifiers. However, these classifiers are less computationally efficient than their linear counterparts. This inefficiency wastes energy, resources and time. We were inspired by the efficiency of the brain to create a novel type of computationally efficient Artificial Neural Network (ANN) called Rank Similarity Filters. They can be used to both transform and classify nonlinearly separable datasets with many datapoints and dimensions. The weights of the filters are set using the rank orders of features in a datapoint, or optionally the 'confusion' adjusted ranks between features (determined from their distributions in the dataset). The activation strength of a filter determines its similarity to other points in the dataset, a measure based on cosine similarity. The activation of many Rank Similarity Filters transforms samples into a new nonlinear space suitable for linear classification (Rank Similarity Transform (RST)). We additionally used this method to create the nonlinear Rank Similarity Classifier (RSC), which is a fast and accurate multiclass classifier, and the nonlinear Rank Similarity Probabilistic Classifier (RSPC), which is an extension to the multilabel case. We evaluated the classifiers on multiple datasets and RSC is competitive with existing classifiers but with superior computational efficiency. Code for RST, RSC and RSPC is open source and was written in Python using the popular scikit-learn framework to make it easily accessible (https://github.com/KatharineShapcott/rank-similarity). In future extensions the algorithm can be applied to hardware suitable for the parallelization of an ANN (GPU) and a Spiking Neural Network (neuromorphic computing) with corresponding performance gains. This makes Rank Similarity Filters a promising biologically inspired solution to the problem of efficient analysis of nonlinearly separable data.

NMC4 Keynote: A network perspective on cognitive effort

Cognitive effort has long been an important explanatory factor in the study of human behavior in health and disease. Yet, the biophysical nature of cognitive effort remains far from understood. In this talk, I will offer a network perspective on cognitive effort. I will begin by canvassing a recent perspective that casts cognitive effort in the framework of network control theory, developed and frequently used in systems engineering. The theory describes how much energy is required to move the brain from one activity state to another, when activity is constrained to pass along physical pathways in a connectome. I will then turn to empirical studies that link this theoretical notion of energy with cognitive effort in a behaviorally demanding task, and with a metabolic notion of energy as accessible to FDG-PET imaging. Finally, I will ask how this structurally-constrained activity flow can provide us with insights about the brain’s non-equilibrium nature. Using a general tool for quantifying entropy production in macroscopic systems, I will provide evidence to suggest that states of marked cognitive effort are also states of greater entropy production. Collectively, the work I discuss offers a complementary view of cognitive effort as a dynamical process occurring atop a complex network.

Spontaneous activity competes with externally evoked responses in sensory cortex

The interaction between spontaneously and externally evoked neuronal activity is fundamental for a functional brain. Increasing evidence suggests that bursts of high-power oscillations in the 15-30 Hz beta-band represent activation of resting state networks and can mask perception of external cues. Yet demonstration of the effect of beta power modulation on perception in real-time is missing, and little is known about the underlying mechanism. In this talk I will present the methods we developed to fill this gap together with our recent results. We used a closed-loop stimulus-intensity adjustment system based on online burst-occupancy analyses in rats involved in a forepaw vibrotactile detection task. We found that the masking influence of burst-occupancy on perception can be counterbalanced in real-time by adjusting the vibration amplitude. Offline analysis of firing-rates and local field potentials across cortical layers and frequency bands confirmed that beta-power in the somatosensory cortex anticorrelated with sensory evoked responses. Mechanistically, bursts in all bands were accompanied by transient synchronization of cell assemblies, but only beta-bursts were followed by a reduction of firing-rate. Our closed loop approach reveals that spontaneous beta-bursts reflect a dynamic state that competes with external stimuli.

NeurotechEU Summit

Our first NeurotechEU Summit will be fully digital and will take place on November 22th from 09:00 to 17:00 (CET). The final programme can be downloaded here. Hosted by the Karolinska Institutet, the summit will provide you an overview of our actions and achievements from the last year and introduce the priorities for the next year. You will also have the opportunity to attend the finals of the 3 minute thesis competition (3MT) organized by the Synapses Student Society, the student charter of NeurotechEU. Good luck to all the finalists: Lynn Le, Robin Noordhof, Adriana Gea González, Juan Carranza Valencia, Lea van Husen, Guoming (Tony) Man, Lilly Pitshaporn Leelaarporn, Cemre Su, Kaya Keleş, Ramazan Tarık Türksoy, Cristiana Tisca, Sara Bandiera, Irina Maria Vlad, Iulia Vadan, Borbála László, and David Papp! Don’t miss our keynote lecture, success stories and interactive discussions with Ms Vanessa Debiais Sainton (Head of Higher Education Unit, European Commission), Prof. Staffan Holmin (Karolinska Institutet), Dr Mohsen Kaboli (BMW Group, member of the NeurotechEU Associates Advisory Committee), and Prof. Peter Hagoort (Max Planck Institute for Psycholinguistics, Donders Institute). Would you like to use this opportunity to network? Please join our informal breakout sessions on Wonder.me at 11:40 CET. You will be able to move from one discussion group to another within 3 sessions: NeurotechEU ecosystem - The Associates Advisory Committee: Synergies in cross-sectoral initiatives Education next: Trans-European education and the European Universities Initiatives - Lessons learned thus far. Equality, diversity and inclusion at NeurotechEU: removing access barriers to education and developing a working, learning, and social environment where everyone is respected and valued. You can register for this free event at www.crowdcast.io/e/neurotecheu-summit

Design principles of adaptable neural codes

Behavior relies on the ability of sensory systems to infer changing properties of the environment from incoming sensory stimuli. However, the demands that detecting and adjusting to changes in the environment place on a sensory system often differ from the demands associated with performing a specific behavioral task. This necessitates neural coding strategies that can dynamically balance these conflicting needs. I will discuss our ongoing theoretical work to understand how this balance can best be achieved. We connect ideas from efficient coding and Bayesian inference to ask how sensory systems should dynamically allocate limited resources when the goal is to optimally infer changing latent states of the environment, rather than reconstruct incoming stimuli. We use these ideas to explore dynamic tradeoffs between the efficiency and speed of sensory adaptation schemes, and the downstream computations that these schemes might support. Finally, we derive families of codes that balance these competing objectives, and we demonstrate their close match to experimentally-observed neural dynamics during sensory adaptation. These results provide a unifying perspective on adaptive neural dynamics across a range of sensory systems, environments, and sensory tasks.

From aura to neuroinflammation: Has imaging resolved the puzzle of migraine pathophysiology?

In this talk I will present data from imaging studies that we have been conducting for the past 20 years trying to shed light on migraine physiopathology, from anatomical and functional MRI to positron emission tomography.

Representation transfer and signal denoising through topographic modularity

To prevail in a dynamic and noisy environment, the brain must create reliable and meaningful representations from sensory inputs that are often ambiguous or corrupt. Since only information that permeates the cortical hierarchy can influence sensory perception and decision-making, it is critical that noisy external stimuli are encoded and propagated through different processing stages with minimal signal degradation. Here we hypothesize that stimulus-specific pathways akin to cortical topographic maps may provide the structural scaffold for such signal routing. We investigate whether the feature-specific pathways within such maps, characterized by the preservation of the relative organization of cells between distinct populations, can guide and route stimulus information throughout the system while retaining representational fidelity. We demonstrate that, in a large modular circuit of spiking neurons comprising multiple sub-networks, topographic projections are not only necessary for accurate propagation of stimulus representations, but can also help the system reduce sensory and intrinsic noise. Moreover, by regulating the effective connectivity and local E/I balance, modular topographic precision enables the system to gradually improve its internal representations and increase signal-to-noise ratio as the input signal passes through the network. Such a denoising function arises beyond a critical transition point in the sharpness of the feed-forward projections, and is characterized by the emergence of inhibition-dominated regimes where population responses along stimulated maps are amplified and others are weakened. Our results indicate that this is a generalizable and robust structural effect, largely independent of the underlying model specificities. Using mean-field approximations, we gain deeper insight into the mechanisms responsible for the qualitative changes in the system’s behavior and show that these depend only on the modular topographic connectivity and stimulus intensity. The general dynamical principle revealed by the theoretical predictions suggest that such a denoising property may be a universal, system-agnostic feature of topographic maps, and may lead to a wide range of behaviorally relevant regimes observed under various experimental conditions: maintaining stable representations of multiple stimuli across cortical circuits; amplifying certain features while suppressing others (winner-take-all circuits); and endow circuits with metastable dynamics (winnerless competition), assumed to be fundamental in a variety of tasks.

Event-based Backpropagation for Exact Gradients in Spiking Neural Networks

Gradient-based optimization powered by the backpropagation algorithm proved to be the pivotal method in the training of non-spiking artificial neural networks. At the same time, spiking neural networks hold the promise for efficient processing of real-world sensory data by communicating using discrete events in continuous time. We derive the backpropagation algorithm for a recurrent network of spiking (leaky integrate-and-fire) neurons with hard thresholds and show that the backward dynamics amount to an event-based backpropagation of errors through time. Our derivation uses the jump conditions for partial derivatives at state discontinuities found by applying the implicit function theorem, allowing us to avoid approximations or substitutions. We find that the gradient exists and is finite almost everywhere in weight space, up to the null set where a membrane potential is precisely tangent to the threshold. Our presented algorithm, EventProp, computes the exact gradient with respect to a general loss function based on spike times and membrane potentials. Crucially, the algorithm allows for an event-based communication scheme in the backward phase, retaining the potential advantages of temporal sparsity afforded by spiking neural networks. We demonstrate the optimization of spiking networks using gradients computed via EventProp and the Yin-Yang and MNIST datasets with either a spike time-based or voltage-based loss function and report competitive performance. Our work supports the rigorous study of gradient-based optimization in spiking neural networks as well as the development of event-based neuromorphic architectures for the efficient training of spiking neural networks. While we consider the leaky integrate-and-fire model in this work, our methodology generalises to any neuron model defined as a hybrid dynamical system.

The brain control of appetite: Can an old dog teach us new tricks?

It is clear that the cause of obesity is a result of eating more than you burn. It is physics. What is more complex to answer is why some people eat more than others? Differences in our genetic make-up mean some of us are slightly more hungry all the time and so eat more than others. We now know that the genetics of body-weight, on which obesity sits on one end of the spectrum, is in actuality the genetics of appetite control. In contrast to the prevailing view, body-weight is not a choice. People who are obese are not bad or lazy; rather, they are fighting their biology.

Merging of cues and hunches by the mouse cortex

Many everyday decisions are based on both external cues and internal hunches. How does the brain put these together? We addressed this question in mice trained to make decisions based on sensory stimuli and on past events. While mice made these decisions, we causally probed the roles of cortical areas and recorded from thousands of neurons throughout the brain, with an emphasis on frontal cortex. The results are not what we thought based on textbook notions of how the brain works. This talk is based on work led by Nick Steinmetz, Peter Zatka-Haas, Armin Lak, and Pip Coen, in the laboratory I share with Kenneth Harris

The attentional requirement of unconscious processing

The tight relationship between attention and conscious perception has been extensively researched in the past decades. However, whether attentional modulation extended to unconscious processes remained largely unknown, particularly when it came to abstract and high-level processing. I will talk about a recent study where we utilized the Stroop paradigm to show that task load gates unconscious semantic processing. In a series of psychophysical experiments, the unconscious word semantics influenced conscious task performance only under the low task load condition, but not the high task load condition. Intriguingly, with enough practice in the high task load condition, the unconscious effect reemerged. These findings suggest a competition of attentional resources between unconscious and conscious processes, challenging the automaticity account of unconscious processing.

3 Minutes Thesis Competition: Pre-selection event

On behalf of NeurotechEU, we are pleased to invite you to participate in the Summit 2021 pre-selection event on October 23, 2021. The event will be held online via the Platform Crowdcast.io, and it is going to be organized by NeurotechEU-The European University of Brain and Technology. Students from all over NeurotechEU have the chance to present their research (bachelor’s thesis, Master’s thesis, PhD, post-doc…) following the methodology of three minutes thesis (3MT from the University of Queensland): https://threeminutethesis.uq.edu.au/resources/3mt-competitor-guide. There will be one session per university and at the end of it, two semi-finalists will be selected from each university. They will compete in the Summit 2021 on November 22nd. There will be prizes for the winners who will be selected by voting of the audience.

Will it keep me awake? Common caffeine intake habits and sleep in real life situations

Daily caffeine consumption and chronic sleep restriction are highly prevalent in society. It is well established that acute caffeine intake under controlled conditions enhances vigilance and promotes wakefulness but can also delay sleep initiation and reduce electroencephalographic (EEG) markers of sleep intensity, particularly in susceptible individuals. To investigate whether these effects are also present during chronic consumption of coffee/caffeine, we recently conducted several complementary studies. We examined whether repeated coffee intake in dose and timing mimicking ‘real world’ habits maintains simple and complex attentional processes during chronic sleep restriction, such as during a busy work week. We found in genetically caffeine-sensitive individuals that regular coffee (300 mg caffeine/day) benefits most attentional tasks for 3-4 days when compared to decaffeinated coffee. Genetic variants were also used in the population-based HypnoLaus cohort, to investigate whether habitual caffeine consumption causally affects time to fall asleep, number of awakenings during sleep, and EEG-derived sleep intensity. The multi-level statistical analyses consistently showed that sleep quality was virtually unaffected when >3 caffeine-containing beverages/day were compared to 0-3 beverages/day. This conclusion was further corroborated by quantifying the sleep EEG in the laboratory in habitual caffeine consumers. Compared to placebo, daily intake of 3 x 150 mg caffeine over 10 days did not strongly impair nocturnal sleep nor subjective sleep quality in good sleepers. Finally, we tested whether an engineered delayed, pulsatile-release caffeine formula can improve the quality of morning awakening in sleep-restricted volunteers. We found that 160 mg caffeine taken at bedtime ameliorated the quality of awakening, increased positive and reduced negative affect scores, and promoted sustained attention immediately upon scheduled wake-up. Such an approach could prevent over-night caffeine withdrawal and provide a proactive strategy to attenuate disabling sleep inertia. Taken together, the studies suggest that common coffee/caffeine intake habits can transiently attenuate detrimental consequences of reduced sleep virtually without disturbing subjective and objective markers of sleep quality. Nevertheless, coffee/caffeine consumption cannot compensate for chronic sleep restriction.

Top-down modulation of the retinal code via histaminergic neurons in the hypothalamus

The mammalian retina is considered an autonomous neuronal tissue, yet there is evidence that it receives inputs from the brain in the form of retinopetal axons. A sub-population of these axons was suggested to belong to histaminergic neurons located in the tuberomammillarynucleus (TMN) of the hypothalamus. Using viral injections to the TMN, we identified these retinopetal axons and found that although few in number, they extensively branch to cover a large portion of the retina. Using Ca2+ imaging and electrophysiology, we show that histamine application increases spontaneous firing rates and alters the light responses of a significant portion of retinal ganglion cells (RGCs). Direct activation of the histaminergic axons also induced significant changes in RGCs activity. Since activity in the TMN was shown to correlate with arousal state, our data suggest the retinal code may change with the animal's behavioral state through the release of histamine from TMN histaminergic neurons.

Metabolic and functional connectivity relate to distinct aspects of cognition

A major challenge of cognitive neuroscience is to understand how the brain as a network gives rise to our cognition. Simultaneous [18F]-fluorodeoxyglucose positron emission tomography functional magnetic resonance imaging (FDG-PET/fMRI) provides the opportunity to investigate brain connectivity not only via spatially distant, synchronous cerebrovascular hemodynamic responses (functional connectivity), but also glucose metabolism (metabolic connectivity). However, how these two modalities of brain connectivity differ in their relation to cognition is unknown. In this webinar, Dr Katharina Voigt will discuss recent findings demonstrating the advantage of simultaneous FDG-PET/fMRI in providing a more complete picture of the neural mechanisms underlying cognition, that calls for a combination of both modalities in future cognitive neuroscience. Dr Katharina Voigt is a Research Fellow within the Turner Institute for Brain and Mental Health, Monash University. Her research interests include systems neuroscience, simultaneous PET-MRI, and decision-making.

THE PHASE OF SLOW WAVE OSCILLATIONS COUPLES WITH HIGH GAMMA POWER IN HUMAN ELECTROCORTICOGRAPHY DURING PERFORMED AND IMAGINED REPETITIVE MOVEMENTS

FENS Forum 2026

Modeling competitive memory encoding using a Hopfield network

Bernstein Conference 2024

The dynamical regime of mouse visual cortex shifts from cooperation to competition with increasing visual input

COSYNE 2022

Neural Representations of Opponent Strategy Support the Adaptive Behavior of Recurrent Actor-Critics in a Competitive Game

COSYNE 2022

Neural Representations of Opponent Strategy Support the Adaptive Behavior of Recurrent Actor-Critics in a Competitive Game

COSYNE 2022

Inhibitory control of plasticity promotes stability and competitive learning in recurrent networks

COSYNE 2023

Instinct vs Insight: Neural Competition Between Prefrontal and Auditory Cortex Constrains Sound Strategy Learning

COSYNE 2025

Understanding stochastic decision-making in competitive multi-agent environments

COSYNE 2025

Activity-dependent modulation of actin dynamics by Cdc42 modulates synaptic cooperation and competition

Assessment of repetitive and compulsive behaviours induced by pramipexole in rats: effect of alpha-synuclein-induced nigrostriatal degeneration

Attenuation of the appetitive response to a cocaine-associated context after an escalating-dose drug regimen is associated with maladaptive changes in the prefrontal cortex

CACNAC 1C genetic model of psychosis IEG´s expression increases in the prefrontal cortex and amygdala after pavlovian appetitive extinction and renewal

Characterising ‘the munchies’; effects of tetrahydrocannabinol (THC) vapour inhalation on rat feeding behaviours and homeostatic appetite-regulating pathways

Chronic intracerebroventricular administration of orexin-A does not modify behavioural outcomes following repetitive mild traumatic brain injury in rats

Collaboration and competition lead to long-term spatial heterosynaptic plasticity

Competing cognitive pressures on human exploration in the absence of trade-off with exploitation

Compulsive Sexual Behavior Disorder Impact On Striatum and Amygdala Functional Responses During Appetitive Conditioning and Extinction

Dapsone prevents hypermetabolic effect of kainic acid in rats: An 18FDG-PET study

Developmental Disruption of Erbb4 in Pet1+ Neurons Impairs Serotonergic Sub-System Connectivity and Memory Formation

Dose dependent effects of TMS on the modulation of fronto-striatal connectivity. A 18F-DMFP PET study

Dynamic and state-dependent switching of behaviour in response to competing visual stimuli in Drosophila

Effects of d-amphetamine on nose-poke responding in an appetitive Pavlovian inhibitory learning task using Wistar rats

Effects of repetitive vibration on force control, proprioception, and neural activities in the CNS

Epigenetic plasticity contributes to neuronal competition during memory allocation

Evaluation of repetitive mild traumatic brain injury by fluorescence and FDG PET imaging

A new gut-brain communication pathway in which bacterial sensing via neuronal Nod2 regulates appetite and body temperature

A Gut-Brain Connection: Gut Microbiome Composition is Differentially Altered After Repetitive Mild Traumatic Brain Injury in Adolescent and Adult Rats

Hydroxynorketamine and ketamine converge on regulation of synaptic vesicle release competence via independent mechanisms

Immunocompetent cerebral spheroids as a model system to evaluate drug-mediated demyelination and to study remyelination

Infusions of a dopamine D1 receptor agonist into the prefrontal cortex and appetitive inhibitory discrimination learning

Low intensity repetitive magnetic stimulation (LI rTMS) effects on a model of pathological cerebellar development

Modeling effects of Repetitive Transcranial Magnetic Stimulation protocols in recurrent neural networks with homeostatic structural plasticity: exploring the rTMS parameter space

Neurocomputational mechanisms engaged in detecting cooperative and competitive intentions of others

Repetitive prefrontal transcranial direct current stimulation alleviates neuropathic pain via neural remodelling

Repetitive Somatosensory Stimulation of a finger affects some metric aspects of its mental representation

Retest-Reliability of Repetitive Transcranial Magnetic Stimulation over the Healthy Human Motor Cortex: A Systematic Review

A role for neurons of the medial division of the central amygdala in appetitive behaviours

Roles of prelimbic and infralimbic prefrontal cortices in an appetitive inhibitory discrimination learning task

The SAPAP3-KO mouse reconsidered as a comorbid model expressing a spectrum of pathological repetitive behaviors

Spinal coding of thermonocicpetion in adult Wistar rat